Life Sciences

In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

08 Mar 2022  |  North America

Global Pharmaceuticals Outlook, 2022

The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders

Infographics

×

Key Issues Addressed

Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...

In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transp...

The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...

Healthcare industry challenges including aging populations, rising incidence of chronic diseases, and the need to manage care costs better are necessitating the adoption of innovative care delivery models. While healthcare providers and consumers are displaying a perceivable behavior shift in the way they interact with health technologies, vendors ...

Demand for healthcare services will continue to grow in Asia-Pacific (APAC) under the influence of demographic and epidemiological transitions impacting the entire region. APAC governments which shoulder the largest burden of paying for healthcare services will take decisive steps to innovate their healthcare systems in order to face future challen...

18 Apr 2016  |  Africa

Africa Healthcare Industry Outlook, 2016

Value-based Transformations in Home Diagnostic Technologies, Exclusive Drugs, and Improved Point of Care Energise Healthcare Ecosystem

Infographics

×

Africa is experiencing a plethora of changes in the healthcare segment. From being the market of imports and low-value manufacturing, the continent is transforming into a region of tailor-made medical equipment that is compatible with telemedicine solutions. There is an increase in the in-country production of pharmaceuticals, smart phone applicati...

This research service provides an analysis for the healthcare market in Vietnam. In addition to an overview of the total healthcare market, it presents detailed analyses of current trends, market sizes, revenue forecasts, and drivers and restraints for the hospital (private and public) market, and for the manufacturing and distribution of medical d...

The research service provides an analysis of the healthcare market in Asia-Pacific (APAC). It discusses the current technology and country-specific trends and provides predictions. Market participants and key opinion leaders in APAC hospitals were interviewed to obtain their views on trends and opportunities in the healthcare industry. The regional...